European ICU Drug Supports Patients in Canada
Vienna (01.02.2021) – Development and clinical data from the European Healthcare company AOP Orphan form the basis of the introduction of a new drug in Canada for rapid heart rate control in the hospital setting. Trimedic Therapeutics is about toWeiter Lesen